Expression of EGFR and Molecules Downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) Pathways in Invasive Lung Adenocarcinomas Resected at a Single Institution
Therapies targeting EGFR are effective in treating tumors that harbor molecular alterations; however, there is heterogeneity in long-term response to these therapies. We retrospectively analyzed protein expression of EGFR, Stat3, phospho-Akt, and phospho-Erk1/2 by immunohistochemistry in a series of...
Main Authors: | Alba Fabiola Torres, Cleto Nogueira, Juliana Magalhaes, Igor Santos Costa, Alessa Aragao, Antero Gomes Neto, Filadelfia Martins, Fabio Tavora |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2014/352925 |
Similar Items
-
Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways
by: K. I. Zarubina, et al.
Published: (2020-09-01) -
Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells
by: Shaojun Wang, et al.
Published: (2019-11-01) -
Crosstalk between PI3 Kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK Pathways Downstream PDGF Receptor
by: Emma Tabe Eko Niba, et al.
Published: (2013-06-01) -
The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
by: Sergio Coffa, et al.
Published: (2011-01-01) -
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
by: Pui-Kei Wu, et al.
Published: (2020-07-01)